Sucharit P, Suntharasamai P, Chintana T, Harinasuta T
Southeast Asian J Trop Med Public Health. 1979 Mar;10(1):138-41.
Forty-four patients with falciparum malaria were studied. Nine patients were given quinine orally at a daily dose of 1.5 gm base for a period of 14 days. The mean parasite clearance in all 9 patients was 3.3 days, and none had recrudescence in follow-up examinations for 31 days. The in vivo study of these 9 patients showed sensitivity to quinine which correlated with the in vitro test, with concentration of quinine base 2.5-5.8 microgram/ml of blood that inhibited the maturation of Plasmodium falciparum parasites. The results of the in vitro test of 35 patients showed concentrations of quinine base 2.1-5.4 microgram/ml of blood were able to inhibit the maturation of P. falciparum parasites. Therefore, these studies indicate that Plasmodium falciparum are still sensitive to quinine and quinine remains to be the drug of choice for the treatment of falciparum malaria in Thailand.
对44例恶性疟患者进行了研究。9例患者口服奎宁,每日剂量为1.5克碱,疗程为14天。所有9例患者的平均寄生虫清除时间为3.3天,在31天的随访检查中均无复发。对这9例患者的体内研究显示对奎宁敏感,这与体外试验相关,奎宁碱浓度为2.5 - 5.8微克/毫升血液时可抑制恶性疟原虫的成熟。35例患者的体外试验结果显示,奎宁碱浓度为2.1 - 5.4微克/毫升血液时能够抑制恶性疟原虫的成熟。因此,这些研究表明恶性疟原虫对奎宁仍然敏感,奎宁仍然是泰国治疗恶性疟的首选药物。